Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (TCTR20250815003) titled 'Topical urea and dermatophytosis' on Aug. 15.
Study Type: Interventional
Study Design:
Randomized
Primary Sponsor: Lady reading hospital peshawar,Pakistan
Condition:
dermatophystosis
Dermatophytosis, Keratolytics, Terbinafine, ,Urea
Dermatophytosis, Keratolytics, Terbinafine, ,Urea
Intervention:
this group received oral terbinafine in combination with 20% topical urea for 6 weeks l terbinafine only,This group received oral terbinafine only for 6 weeks
Active Comparator Drug,Active Comparator Drug
Recruitment Status: Not Recruiting
Phase: Phase 2
Date of First Enrollment: 01/09/2025
Target Sample Siz...